Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24787296)

1.

Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.

Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Ludovico Rapaccini G, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group.

Semin Oncol. 2014 Apr;41(2):252-8. doi: 10.1053/j.seminoncol.2014.03.006. Epub 2014 Mar 6.

2.

Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.

Carr BI, Guerra V, Pancoska P.

Oncology. 2012;83(6):339-45. doi: 10.1159/000342431. Epub 2012 Sep 18.

PMID:
23006937
3.

Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.

Carr BI, Guerra V.

Oncology. 2013;85(3):153-9. doi: 10.1159/000354416. Epub 2013 Aug 29.

4.

Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.

Carr BI, Pancoska P, Giannini EG, Farinati F, Ciccarese F, Ludovico Rapaccini G, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer Group.

Semin Oncol. 2014 Jun;41(3):406-14. doi: 10.1053/j.seminoncol.2014.04.002. Epub 2014 Apr 24.

PMID:
25023357
5.

Small hepatocellular carcinomas and thrombocytopenia.

Carr BI, Guerra V, De Giorgio M, Fagiuoli S, Pancoska P.

Oncology. 2012;83(6):331-8. doi: 10.1159/000341533. Epub 2012 Sep 18.

PMID:
23006906
6.

Low alpha-fetoprotein HCC and the role of GGTP.

Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F.

Int J Biol Markers. 2014 Dec 9;29(4):e395-402. doi: 10.5301/jbm.5000092.

PMID:
24832180
7.

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

Giannini EG, Sammito G, Farinati F, Ciccarese F, Pecorelli A, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Gasbarrini A, Sacco R, Foschi FG, Missale G, Morisco F, Svegliati Baroni G, Virdone R, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group.

Cancer. 2014 Jul 15;120(14):2150-7. doi: 10.1002/cncr.28706. Epub 2014 Apr 10.

PMID:
24723129
8.

Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.

Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney A.

J Vasc Interv Radiol. 2004 Apr;15(4):335-45.

PMID:
15064336
9.

Features of massive hepatocellular carcinomas.

Carr BI, Guerra V.

Eur J Gastroenterol Hepatol. 2014 Jan;26(1):101-8. doi: 10.1097/MEG.0b013e3283644c49.

PMID:
23863262
10.

Platelet-related phenotypic patterns in hepatocellular carcinoma patients.

Carr BI, Lin CY, Lu SN.

Semin Oncol. 2014 Jun;41(3):415-21. doi: 10.1053/j.seminoncol.2014.04.001. Epub 2014 Apr 23.

PMID:
25023358
11.

Significance of platelet and AFP levels and liver function parameters for HCC size and survival.

Carr BI, Guerra V, Giannini EG, Farinati F, Ciccarese F, Rapaccini GL, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer Group.

Int J Biol Markers. 2014 Sep 30;29(3):e215-23. doi: 10.5301/jbm.5000064.

PMID:
24526315
12.

Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.

Liu C, Xiao GQ, Yan LN, Li B, Jiang L, Wen TF, Wang WT, Xu MQ, Yang JY.

World J Gastroenterol. 2013 Mar 21;19(11):1811-9. doi: 10.3748/wjg.v19.i11.1811.

13.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

14.

Macro- and micro-environmental factors in clinical hepatocellular cancer.

Pancoska P, Carr BI.

Semin Oncol. 2014 Apr;41(2):185-94. doi: 10.1053/j.seminoncol.2014.03.001. Epub 2014 Mar 7.

16.

Significance of increased serum GGTP levels in HCC patients.

Carr BI, Pancoska P, Branch RA.

Hepatogastroenterology. 2010 Jul-Aug;57(101):869-74.

PMID:
21033244
17.

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30.

PMID:
24388339
18.

Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization.

Wang Y, Chen Y, Ge N, Zhang L, Xie X, Zhang J, Chen R, Wang Y, Zhang B, Xia J, Gan Y, Ren Z, Ye S.

Ann Surg Oncol. 2012 Oct;19(11):3540-6. doi: 10.1245/s10434-012-2368-5. Epub 2012 Apr 25.

PMID:
22532305
19.

Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.

Hu HT, Kim JH, Lee LS, Kim KA, Ko GY, Yoon HK, Sung KB, Gwon DI, Shin JH, Song HY.

J Vasc Interv Radiol. 2011 Jul;22(7):917-23. doi: 10.1016/j.jvir.2011.03.005. Epub 2011 May 14.

PMID:
21571545
20.

Is inconsistency of alpha-fetoprotein level a good prognosticator for hepatocellular carcinoma recurrence?

Hsieh CB, Chen TW, Chu CM, Chu HC, Yu CP, Chung KP.

World J Gastroenterol. 2010 Jun 28;16(24):3049-55.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk